OmniAb, Inc. (OABI)
NASDAQ: OABI · Real-Time Price · USD
4.760
-0.030 (-0.63%)
Oct 12, 2026, 12:26 PM EDT - Market open
OmniAb Market Cap
OmniAb has a market cap or net worth of $692.06 million as of October 12, 2026. It is the 12,607th most valuable company in the world and the 2,514th biggest in the United States. Its market cap has increased by 197.67% in one year.
Market Cap
692.06M
Enterprise Value
658.98M
1-Year Change
197.67%
Global Rank
Country Rank
#2,514 United States
Category
ChartMarket Cap Chart
Since October 25, 2022, OmniAb's market cap has decreased from $992.92M to $692.06M, a decrease of -30.30%. That is a compound annual growth rate of -8.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 12, 2026 | 692.06M | 159.86% |
| Dec 31, 2025 | 266.32M | -37.83% |
| Dec 31, 2024 | 428.38M | -40.30% |
| Dec 29, 2023 | 717.57M | 73.60% |
| Dec 30, 2022 | 413.36M | -58.37% |
| Oct 25, 2022 | 992.92M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 732.05M |
| Design Therapeutics | 729.08M |
| Prime Medicine | 709.84M |
| Pharming Group | 694.55M |
| Nuvectis Pharma | 688.12M |
| Olema Pharmaceuticals | 684.23M |
| Wave Life Sciences | 681.79M |
| MiMedx Group | 680.70M |